Evidence map›Paper›PMID 39144061›Full record

ArticleQuantitative imaging in medicine and surgery2024

Predictive performance of [

Chunhui Wu, Fang Wen, Fangzeng Lin, Yu Zeng, Xiaojie Lin, Xin Hu, Xiangsong Zhang, Xinhua Zhang, Xiaoyan Wang

Abstract read
In one paragraph

Article in Quantitative imaging in medicine and surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Observational
  4. Review
  5. Article
  6. Fibroblast Activation Protein Inhibitor (FAPI)-Based Theranostics.Pharmaceuticals (Basel, Switzerland) · 2025
    Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Chunhui Wu *Department of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Fang Wen *Department of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Fangzeng Lin *Department of Radiology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Yu ZengDepartment of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Xiaojie LinDepartment of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Xin HuDepartment of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Xiangsong ZhangDepartment of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Xinhua ZhangCenter of Gastrointestinal Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Xiaoyan WangDepartment of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.ORCID https://orcid.org/0000-0002-8633-1825

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Accurately and promptly predicting the response of gastrointestinal stromal tumors (GISTs) to targeted therapy is essential for optimizing treatment strategies. However, some fractions of recurrent or metastatic GISTs present as non-FDG-avid lesions, limiting the value of [ Methods: Our retrospective analysis included 27 patients with recurrent or metastatic GISTs who underwent [ Results: A total of 110 lesions were identified in 27 patients. Compared with PG, NPG was associated with lower levels of TBR and SUV Conclusions: Both [

Indexed as

fibroblast activation protein inhibitor positron emission tomography/computed tomography (FAPI PET/CT)Fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT)gastrointestinal stromal tumors (GISTs)response prediction

Identifiers

PMID39144061
PMCPMC11320500

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.